RECORD // Company

Curaleaf Holdings, Inc.

Built 2026-11-21T11:38:05Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (4)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • CURALEAF HOLDINGS, INC. · East licences · same registered legal name as 'Curaleaf Holdings, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CURALEAF HOLDINGS, INC. · East licences · same registered legal name as 'Curaleaf Holdings, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CURALEAF HOLDINGS, INC. · East licences · same registered legal name as 'Curaleaf Holdings, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • CURALEAF HOLDINGS LLC · Ny corps · name equals 'Curaleaf Holdings' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare

7 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-03 · accession 0001628280-26-069653

ItemValuePeriodFormFiledAccessionReport
Revenue$352,650,0003 months ended 2026-09-3010-Q2026-11-030001628280-26-0696532026-11-21 11:38 UTCReport an error
Net income (loss)$-32,721,0003 months ended 2026-09-3010-Q2026-11-030001628280-26-0696532026-11-21 11:38 UTCReport an error
Cash and cash equivalents$92,387,000at 2026-09-3010-Q2026-11-030001628280-26-0696532026-11-21 11:38 UTCReport an error
Contract liabilities, current$1,386,000at 2026-09-3010-Q2026-11-030001628280-26-0696532026-11-21 11:38 UTCReport an error
Debt due in the next 12 months$47,530,000at 2026-09-3010-Q2026-11-030001628280-26-0696532026-11-21 11:38 UTCReport an error
Debt due in year 2$3,978,000at 2026-09-3010-Q2026-11-030001628280-26-0696532026-11-21 11:38 UTCReport an error
Debt due in year 3$570,311,000at 2026-09-3010-Q2026-11-030001628280-26-0696532026-11-21 11:38 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001756770
Ticker
CURLF
Record ID
sx:sec:0001756770

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

24 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-10SEC EDGAR company profile2026-11-21 11:38 UTCReport an error
SIC industry2833 Medicinal Chemicals & Botanical Products2026-11-10SEC EDGAR company profile2026-11-21 11:38 UTCReport an error
State of incorporationA12026-11-10SEC EDGAR company profile2026-11-21 11:38 UTCReport an error
Fiscal year end (MMDD)12312026-11-10SEC EDGAR company profile2026-11-21 11:38 UTCReport an error
Business address250 HARBOR DRIVE, THIRD FLOOR, STAMFORD, CT, 069022026-11-10SEC EDGAR company profile2026-11-21 11:38 UTCReport an error
ExchangesOTC2026-11-10SEC EDGAR company profile2026-11-21 11:38 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$1,268,135,0002025-12-3140-F, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:38 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-231,070,0002025-12-3140-F, XBRL NetIncomeLoss2026-11-21 11:38 UTCReport an error
Total assets (at 2025-12-31)$2,845,315,0002025-12-3140-F, XBRL Assets2026-11-21 11:38 UTCReport an error
Stockholders' equity (at 2025-12-31)$756,350,0002025-12-3140-F, XBRL StockholdersEquity2026-11-21 11:38 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$101,573,0002025-12-3140-F, XBRL CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2026-11-21 11:38 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$137,706,0002025-12-3140-F, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:38 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$63,440,0002025-12-3140-F, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:38 UTCReport an error
Long-term debt (at 2025-12-31)$548,652,0002025-12-3140-F, XBRL LongTermDebt2026-11-21 11:38 UTCReport an error
Operating lease liabilities (at 2025-12-31)$122,183,0002025-12-3140-F, XBRL OperatingLeaseLiability2026-11-21 11:38 UTCReport an error
Form D total offering amount (D filed 2026-03-11)$345,030,0002026-03-11D2026-11-21 11:38 UTCReport an error
Form D total amount sold (D filed 2026-03-11)$345,030,0002026-03-11D2026-11-21 11:38 UTCReport an error
Form D industry groupOther2026-03-11D2026-11-21 11:38 UTCReport an error
Form D revenue rangeDecline to Disclose2026-03-11D2026-11-21 11:38 UTCReport an error
Form D date of first sale2026-02-182026-03-11D2026-11-21 11:38 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-11-10)On November 10, 2026, Curaleaf Holdings, Inc. ("Curaleaf") issued a statement confirming the company has received all required competition law clearances for proposed acquisition of Aurora Cannabis. In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as…2026-11-10SEC EDGAR 8-K 0001628280-26-072647 (text as filed, excerpt)2026-11-21 11:38 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-11-05)On November 3, 2026, Curaleaf Holdings, Inc. ("Curaleaf") issued a statement regarding the alternative proposal for Aurora Cannabis. A copy of the press release is attached as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be…2026-11-05SEC EDGAR 8-K 0001628280-26-070782 (text as filed, excerpt)2026-11-21 11:38 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-03)On November 3, 2026, Curaleaf Holdings, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026, a copy of which is attached as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be…2026-11-03SEC EDGAR 8-K 0001628280-26-069455 (text as filed, excerpt)2026-11-21 11:38 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-03)On November 2, 2026, Curaleaf Holdings, Inc. issued a press release announcing its acquisition of an equity interest in Boone Town Provisions, a copy of which is attached as Exhibit 99.1. The information contained in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific…2026-11-03SEC EDGAR 8-K 0001628280-26-069025 (text as filed, excerpt)2026-11-21 11:38 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.